MARKET

ERNA

ERNA

Ernexa
NASDAQ
0.3763
-0.3037
-44.66%
After Hours: 0.3645 -0.0118 -3.14% 19:57 02/06 EST
OPEN
0.4000
PREV CLOSE
0.6800
HIGH
0.4183
LOW
0.3105
VOLUME
3.93M
TURNOVER
--
52 WEEK HIGH
5.55
52 WEEK LOW
0.3105
MARKET CAP
2.95M
P/E (TTM)
-0.0707
1D
5D
1M
3M
1Y
5Y
1D
Nasdaq Jumps Over 400 Points; AutoNation Shares Surge Following Q4 Earnings
Benzinga · 1d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 1d ago
Dow Jumps Over 600 Points; Amazon Shares Dip After Q4 Results
Benzinga · 1d ago
Ernexa Therapeutics prices 21M shares at 50c in public offering
TipRanks · 1d ago
Ernexa Therapeutics Prices Registered Public Offering Of 21M Shares And Warrants At $0.50 Per Share And Accompanying Warrant
Benzinga · 1d ago
Ernexa Therapeutics Announces $10.5 Million Offering With Warrants to Purchase 21 Million Shares
Reuters · 1d ago
ERNEXA THERAPEUTICS ANNOUNCES PRICING OF $10.5 MILLION PUBLIC OFFERING
Reuters · 1d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 1d ago
More
About ERNA
Ernexa Therapeutics Inc., formerly Eterna Therapeutics Inc., is a preclinical-stage company. The Company is focused on using cutting-edge gene-editing tools to deliver safe off-the-shelf cell therapies for the treatment of advanced solid tumors. Its Pipeline includes ERNA-101, and ERNA-102. Its core technology utilizes engineer allogenic-induced pluripotent stem cells (iPSCs) to express genes of interest and to efficiently differentiate these cells into mesenchymal stem cells (iMSCs). The Company seeks to capitalize on the intrinsic tumor-homing ability of MSCs to slip through the tumor’s defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment (TME), thus unleashing potent anti-cancer immune responses. The Company is focused on developing iPSC-derived iMSC that express critical factors, such as pro-inflammatory cytokines.

Webull offers Ernexa Therapeutics Inc stock information, including NASDAQ: ERNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ERNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ERNA stock methods without spending real money on the virtual paper trading platform.